Author
Listed:
- Hui Zhou
(Wuhan University School of Pharmaceutical Sciences
Tibet University)
- Xiaodong Zeng
(Wuhan University School of Pharmaceutical Sciences
Shenzhen Institute of Wuhan University)
- Anguo Li
(Wuhan University School of Pharmaceutical Sciences)
- Wenyi Zhou
(Wuhan University School of Pharmaceutical Sciences
Shenzhen Institute of Wuhan University)
- Lin Tang
(Wuhan University School of Pharmaceutical Sciences)
- Wenbo Hu
(Nanjing University of Posts and Telecommunications)
- Quli Fan
(Nanjing University of Posts and Telecommunications)
- Xianli Meng
(Chengdu University of Traditional Chinese Medicine, Wenjiang)
- Hai Deng
(University of Aberdeen)
- Lian Duan
(Wuhan University School of Pharmaceutical Sciences)
- Yanqin Li
(Wuhan University School of Pharmaceutical Sciences)
- Zixin Deng
(Wuhan University School of Pharmaceutical Sciences)
- Xuechuan Hong
(Wuhan University School of Pharmaceutical Sciences
Tibet University)
- Yuling Xiao
(Wuhan University School of Pharmaceutical Sciences
Shenzhen Institute of Wuhan University)
Abstract
NIR-II fluorophores have shown great promise for biomedical applications with superior in vivo optical properties. To date, few small-molecule NIR-II fluorophores have been discovered with donor-acceptor-donor (D-A-D) or symmetrical structures, and upconversion-mitochondria-targeted NIR-II dyes have not been reported. Herein, we report development of D-A type thiopyrylium-based NIR-II fluorophores with frequency upconversion luminescence (FUCL) at ~580 nm upon excitation at ~850 nm. H4-PEG-PT can not only quickly and effectively image mitochondria in live or fixed osteosarcoma cells with subcellular resolution at 1 nM, but also efficiently convert optical energy into heat, achieving mitochondria-targeted photothermal cancer therapy without ROS effects. H4-PEG-PT has been further evaluated in vivo and exhibited strong tumor uptake, specific NIR-II signals with high spatial and temporal resolution, and remarkable NIR-II image-guided photothermal therapy. This report presents the first D-A type thiopyrylium NIR-II theranostics for synchronous upconversion-mitochondria-targeted cell imaging, in vivo NIR-II osteosarcoma imaging and excellent photothermal efficiency.
Suggested Citation
Hui Zhou & Xiaodong Zeng & Anguo Li & Wenyi Zhou & Lin Tang & Wenbo Hu & Quli Fan & Xianli Meng & Hai Deng & Lian Duan & Yanqin Li & Zixin Deng & Xuechuan Hong & Yuling Xiao, 2020.
"Upconversion NIR-II fluorophores for mitochondria-targeted cancer imaging and photothermal therapy,"
Nature Communications, Nature, vol. 11(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-19945-w
DOI: 10.1038/s41467-020-19945-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-19945-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.